Máté Hidvégi
| Mate Hidvegi | |
|---|---|
Mate Hidvegi
|
|
| Born |
9 November 1955 Budapest, Hungary |
| Nationality | Hungarian |
| Fields | cancer research |
| Institutions | Budapest University of Technology and Economics, freelance |
| Alma mater | Budapest University of Technology and Economics |
| Known for | Fermented wheat germ extract |
| Notable awards | Jedlik Anyos Prize 2007 |
Mate Hidvegi (born 9 November 1955 in Budapest, Hungary) is a Hungarian biochemist and co-inventor of Avemar and Oncomar, fermented wheat germ extract based nutraceuticals.
Hidvegi was born in Budapest, Hungary, on 9 November 1955. He studied, then taught at what is now Budapest University of Technology and Economics. After finishing university, he worked in the cereal industry and was co-developer of a patented feed advisory system based on near infrared ingredient data. Hidvegi was the pioneer in the development of technologies of mass-production and therapeutic use of instantized herbal extracts in Hungary. Between 1988-1990 Hidvegi was Post-Doctoral Fellow at the Grain Research Laboratory of the Canadian Grain Commission, Winnipeg, Canada.
In 1996 Hidvegi was co-founder of Biromedicina (joint stock company), what is now called The First Hungarian Corporation for Cancer Research and Oncology. The company’s mission was to market Hidvegi's product Avemar, a fermented wheat germ extract-based nutraceutical.
Hidvegi holds a PhD and a Dr. Habil in chemistry, and an honorary professorship at the Jewish University, Budapest.
Hidvegi's first publications were about the theories of the origins of life, and the elaboration of a plausible mechanism for the biogenesis and evolution of biomembranes. He worked out the metabolic map as well as the reaction kinetics of a theoretical first living cell.
Hidvegi invented and hold the patent for the manufacturing process of an alfalfa-based extract (Esterin), which has been claimed to lower serum cholesterol levels (U.S patent 5,277,910 January 11, 1994).
Hidvegi is the co-inventor of a patented fermented wheat germ extract-based nutraceutical known as Avemar. In the U.S., Avemar is classified as a dietary supplement and marketed under the trade name Ave (American BioSciences, Inc.; Blauvelt, NY). In Hungary Avemar as a dietary food for cancer patients.
In 2009 Hidvegi marketed a new dietary food for special medical purposes for cancer patients based on the Avemar, which was sold as Oncomar and (in the U.S.) AvéUltra.
...
Wikipedia